Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Diagnostic Laboratory, |
RCV000202786 | SCV000258201 | uncertain significance | not specified | 2014-12-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001522500 | SCV001732060 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002517357 | SCV003680941 | likely benign | Inborn genetic diseases | 2022-09-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001522500 | SCV004146714 | likely benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | COL18A1: BP4 |
Laboratory of Diagnostic Genome Analysis, |
RCV001522500 | SCV001799926 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001522500 | SCV001966310 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004553107 | SCV004753103 | likely benign | COL18A1-related disorder | 2022-01-28 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |